产品
编 号：F059429
分子式：C22H25F2NO4
分子量：405.44
分子式：C22H25F2NO4
分子量：405.44
产品类型
规格
价格
是否有货
结构图
CAS No: 118457-14-0
产品详情
生物活性：
Nebivolol (R 065824) is an orally active beta receptor blocker and has the high beta(1)-receptor affinity. Nebivolol has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease.
体外研究：
Nebivolol improves endothelial dysfunction via its strong stimulatory effects on the activity of the endothelial nitric oxide synthase and via its antioxidative properties. Nebivolol (0.1 μM-10 μM, 1, 2, 4, 7 or 14 days) inhibits haCSMC or haEC proliferation with IC50 values of ~ 6.0 μM.Nebivolol (0.1 μM-10 μM, 24 h) induces a moderate rate of apoptosis.Nebivolol (0.1, 1, 5,10 μM, 4 days)increases NO formationand decreases endothelin-1 secretion in HaCEs
Nebivolol (R 065824) is an orally active beta receptor blocker and has the high beta(1)-receptor affinity. Nebivolol has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease.
体外研究：
Nebivolol improves endothelial dysfunction via its strong stimulatory effects on the activity of the endothelial nitric oxide synthase and via its antioxidative properties. Nebivolol (0.1 μM-10 μM, 1, 2, 4, 7 or 14 days) inhibits haCSMC or haEC proliferation with IC50 values of ~ 6.0 μM.Nebivolol (0.1 μM-10 μM, 24 h) induces a moderate rate of apoptosis.Nebivolol (0.1, 1, 5,10 μM, 4 days)increases NO formationand decreases endothelin-1 secretion in HaCEs
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备